留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

基于UHPLC-Q-TOF/MS的地榆化学成分分析及大鼠体内代谢研究

裴玉琼 徐坠成 王艳天 顾欣 盛先杰 徐艺 缪志伟

裴玉琼, 徐坠成, 王艳天, 顾欣, 盛先杰, 徐艺, 缪志伟. 基于UHPLC-Q-TOF/MS的地榆化学成分分析及大鼠体内代谢研究[J]. 南京中医药大学学报, 2021, 37(6): 897-907. doi: 10.14148/j.issn.1672-0482.2021.0897
引用本文: 裴玉琼, 徐坠成, 王艳天, 顾欣, 盛先杰, 徐艺, 缪志伟. 基于UHPLC-Q-TOF/MS的地榆化学成分分析及大鼠体内代谢研究[J]. 南京中医药大学学报, 2021, 37(6): 897-907. doi: 10.14148/j.issn.1672-0482.2021.0897
PEI Yu-qiong, XU Zhui-cheng, WANG Yan-tian, GU Xin, SHENG Xian-jie, XU Yi, MIAO Zhi-wei. Identification of Chemical Composition of Sanguisorba officinalis L. and Its Major Metabolites in Rats by UHPLC-Q-TOF/MS[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(6): 897-907. doi: 10.14148/j.issn.1672-0482.2021.0897
Citation: PEI Yu-qiong, XU Zhui-cheng, WANG Yan-tian, GU Xin, SHENG Xian-jie, XU Yi, MIAO Zhi-wei. Identification of Chemical Composition of Sanguisorba officinalis L. and Its Major Metabolites in Rats by UHPLC-Q-TOF/MS[J]. Journal of Nanjing University of traditional Chinese Medicine, 2021, 37(6): 897-907. doi: 10.14148/j.issn.1672-0482.2021.0897

基于UHPLC-Q-TOF/MS的地榆化学成分分析及大鼠体内代谢研究

doi: 10.14148/j.issn.1672-0482.2021.0897
基金项目: 

江苏省中医药科技发展计划 RC201903

江苏省“333高层次人才培养工程”科研项目 LGY2018060

苏州市科技发展计划 SYS2020056

南京中医药大学自然科学基金 XZR2020059

详细信息
    作者简介:

    裴玉琼, 女, 实验师, E-mail: 832002@njucm.edu.cn

    通讯作者:

    缪志伟, 男, 主治中医师, 主要从事脾胃病的方药研究, E-mail: zjgzy011@njucm.edu.cn

    徐艺, 女, 主任中医师, 主要从事脾胃病的中医药防治研究, E-mail: fsyy00638@njucm.edu.cn

  • 中图分类号: R284

Identification of Chemical Composition of Sanguisorba officinalis L. and Its Major Metabolites in Rats by UHPLC-Q-TOF/MS

  • 摘要: 目的  采用超高效液相色谱和-四级杆串联飞行时间质谱(UHPLC-Q-TOF/MS)法分析地榆水提物在大鼠血清、尿液及粪便中的原型成分及代谢产物, 探讨地榆中活性成分在大鼠体内的代谢途径。方法  采用Thermo AcclaimTM RSLC 120 C18色谱柱(3.0 mm×100 mm, 2.2 μm), 以0.1%甲酸水溶液(A)-乙腈(B)为流动相进行梯度洗脱, 流速0.4 mL·min-1, 进样量3 μL, 柱温40 ℃。运用电喷雾离子源(ESI), 扫描范围m/z 50~1 500, 正、负离子模式采集数据。通过比较灌胃地榆水提物后大鼠血清、尿液和粪便样品和空白组样品的差异, 对原型成分及其代谢产物进行鉴定。结果  灌胃给予地榆水提物后, 从大鼠血清、尿液及粪便中鉴定出69个外源性成分, 包括24个原型成分和45个代谢产物。其中24个原型成分包括16个酚类成分、7个三萜类成分及1个单萜烯醇苷。地榆水提物在大鼠体内的代谢途径主要包括还原、甲基化、脱水、氧化、硫酸化及葡萄糖醛酸结合等。结论  所鉴定出的原型成分和代谢产物可为进一步解析地榆体内代谢过程, 阐明其药效物质基础提供实验依据。

     

  • 图  1  地榆水提物和对照品在正、负离子模式下的基峰离子色谱

    注: *表示化合物与对照品确认。

    图  2  地榆皂苷Ⅰ(A)、地榆皂苷Ⅱ(B)和地榆皂苷Ⅲ(C)的MS/MS

    图  3  鞣花酸化合物的代谢途径

    图  4  地榆皂苷Ⅰ的代谢途径

    表  1  地榆水提物化学成分鉴定

    峰号 tR/min 化合物 分子式 m/z[M-H/+HCOO]- 碎片离子 m/z[M+H]+ 碎片离子
    理论值 实测值 δ 理论值 实测值 δ
    C1 1.43 没食子酸糖苷
    (Gallic acid glycoside)
    C13H16O10 331.067 1 331.067 0 -0.3 271.045 1, 211.023 9,
    169.013 2,125.023
    8
    333.081 6 333.081 4 -0.7
    C2 1.85 没食子酸*(Gallic acid) C7H6O5 169.014 3 169.015 0 4.5 125.023 3 171.028 8 171.028 7 -0.8
    C3 3.7 没食子儿茶素(Gallocatechin) C15H14O7 305.066 7 305.067 0 1.0 219.064 5,179.033 7,
    137.023 5,125.023
    8
    307.081 2 307.081 5 0.7
    C4 3.73 表没食子儿茶素
    (Epigallocatechin)
    C15H14O7 305.066 7 305.067 0 1.0 247.023 4 307.081 2 307.081 5 0.7
    C5 5.34 没食子酰基-甲基葡萄糖苷
    (Methyl-6-O-galloyl-β-D-
    glucopyranoside)
    C14H18O10 345.082 7 345.082 8 0.2 313.054 1,169.013 2 347.097 3 347.097 4 0.4 315.071 1,
    171.028 5
    C6 5.57 表儿茶素-(4→8)-没食
    子儿茶素(Epicatechin-
    (4→8)-gallocatechin)
    C30H26O13 593.130 1 593.129 5 -0.9 441.081 8,423.072 6,
    305.066
    9,283.025 2,
    255.029 9
    595.144 6 595.144 0 -1.1 455.350 1,
    437.338 8
    C7 6.71 Sanguiin H4 C27H22O18 633.073 3 633.072 8 -0.9 300.997 6 635.087 9 635.087 3 -0.9
    C8 7.32 原花青素B3
    (Procyanidin B3)
    C30H26O12 577.135 2 577.134 8 -0.7 425.086 8,407.076 2 579.149 7 579.148 8 -1.6 427.102 3,
    409.091 9
    C9 7.48 6-O-Galloylnorbergerin C20H18O13 467.082 0 467.081 7 -0.7 315.066 1
    C10 7.53 二没食子酰葡萄糖苷
    (Bisgalloyl glucoside)
    C20H20O14 483.078 0 483.077 3 -1.5 331.064 0,313.055 1,
    271.044
    6,211.023 4,
    193.006 9,169.012
    5
    485.092 6 485.092 9 0.6
    C11 7.63 原花青素C2(Procyanidin C2) C45H38O18 865.198 5 865.198 8 0.3 695.143 7,577.137 0,
    407.075 2
    867.213 1 867.212 1 -1.1
    C12 7.86 儿茶素*(Catechin) C15H14O6 289.071 8 289.071 9 0.4 441.082 9,245.079 9,
    203.070 2
    291.086 3 291.086 3 0 165.054 3,
    147.044
    2, 139.039 0,
    123.044 6
    C13 7.89 表儿茶素(Epicatechin) C15H14O6 289.071 8 289.071 9 0.4 245.080 6,203.070 3,
    161.059 6
    291.086 3 291.086 3 0
    C14 8.66 三没食子酰葡萄糖苷
    (Trigalloyl glucoside)
    C27H24O18 635.089 0 635.088 2 -1.3 483.076 3,465.066 3,
    313.053 9,221.020
    2
    637.103 5 637.102 3 -1.9
    C15 8.95 短叶苏木酚酸
    (Brevifolincarboxylic acid)
    C13H8O8 291.014 6 291.014 8 0.6 247.060 0,203.070 3 293.029 2 293.029 3 0.3 273.073 3
    C16 9.09 二没食子酰基-D-甲基吡喃
    葡萄糖苷(Methyl 4,6-di-O-
    galloyl-β-D-glucopyranoside)
    C21H22O14 497.093 7 497.092 8 -1.8 497.093 5,345.082 3 499.108 2 499.107 8 -1
    C17 9.31 2, 6-乙酰氧基-5, 7-二羟
    基-8-甲氧基色原酮(2,6-
    Acetoxy-5,7-dihydroxy-8-
    methoxychromone)
    C14H12O9 323.040 9 323.040 6 -0.8 325.055 4 325.055 2 -0.6 293.029 2
    C18 9.32 没食子酰鞣花酸
    (Galloyl ellagic acid)
    C21H10O13 469.004 9 469.004 9 0 316.994 0,300.998 7 471.019 4 471.019 1 -0.8
    C19 9.35 地榆酸双内酯
    (Dilin dilactone)
    C21H10O13 469.004 9 469.004 9 0 314.978 3,300.998 7,
    286.983 7,230.992
    4
    471.019 4 471.019 1 -0.8
    C20 9.72 甲氧基没食子酸甲酯-5-O-硫酸酯(Methyl methoxygallate-5-O-sulfate) C9H10SO8 277.002 4 277.002 4 0 197.043 9,182.020 2,
    166.996
    7,139.002 7,
    123.007 4
    279.016 9 279.016 7 -0.9 199.059 7
    C21 10 3-O-没食子酰基-原花青素B3(3-O-Galloylprocyanidin B3) C37H30O16 729.146 1 729.146 1 -0.1 577.136 1,407.076 8 731.160 7 731.159 1 -2.1
    C22 10.47 非瑟酮醇-(4β-8)-儿茶素(Fisetinol-(4β-8)-catechin) C30H26O11 561.140 2 561.139 5 -1.3 409.092 7,391.081 7,
    289.070
    7,245.080 5,
    203.069 1
    563.154 8 563.153 8 -1.8
    C23 10.69 鞣花酸-4-吡喃阿拉伯糖苷(Ellagic acid-4-arabinopyranoside) C19H14O12 433.041 3 433.040 5 -1.8 435.055 8 435.056 1 0.6 303.013 1
    C24 11.02 2, 3, 4, 6-O-四没食子酰基-β-D-葡萄糖苷(2,3,4,6-O-Tetragalloyl-β-D-glucoside) C34H28O22 787.100 0 787.100 0 0.1 635.089 3,617.077 1,
    465.065
    9,447.056 6,
    313.055 1,295.045
    1
    789.114 5 789.113 5 -1.3
    C25 11.31 鞣花酸*(Ellagic acid) C14H6O8 300.999 0 300.998 8 -0.7 300.996 3,283.995 6,
    229.012 6
    303.013 5 303.013 3 -0.9
    C26 11.58 三没食子酰基-β-D-甲
    基葡萄糖苷(Trigalloyl-
    β-D-Methyl glucoside)
    C28H26O18 649.104 6 649.104 1 -0.8 497.094 6,479.085 1,
    345.082 1,327.070
    6
    651.119 2 651.118 2 -1.5
    C27 11.63 儿茶素没食子酸酯
    (Catechin gallate)
    C22H18O10 441.082 7 441.081 7 -2.4 441.082 9,289.071 0,
    245.079 9,203.070
    2
    443.097 3 443.096 6 -1.5
    C28 11.69 金丝桃苷(Hyperoside) C21H20O12 463.088 2 463.087 5 -1.6 463.088 7,301.034 6 465.102 8 465.102 2 -1.2
    C29 11.9 五没食子酰葡萄糖苷
    (Pentagalloyl glucoside)
    C41H32O26 939.110 9 939.110 6 -0.3 769.093 4,
    617.081 0,
    169.013 2
    C30 12.63 2-甲基-3-乙酰氧基-苯并呋喃-5, 6-O-硫酸酯(2-Methyl-3-acetoxy-benzofuran-5,6-O-sulfate) C12H12O11S2 394.974 8 394.970 5 -11 315.013 1,299.989 4 396.989 4 396.985 6 -9.5
    C31 15.54 3, 4'-O-二甲基鞣花酸-4-O-β-D-木糖苷(3, 4'-O-Dimethylellagic acid-4-O-β-D-xyloside) C21H18O12 461.072 6 461.071 5 -2.3 329.029 5,314.006 3,
    298.982 0,285.003
    0
    463.087 1 463.086 2 -2.1
    C32 15.61 3, 4'-O-二甲基鞣花酸(3,4'-O-Dimethyl ellagic acid) C16H10O8 329.030 3 329.029 6 -2.1 314.004 0,298.980 2,
    285.001 5,258.015
    0
    331.044 8 331.044 6 -0.8
    C33 15.63 3, 4'-O-二甲基鞣花酸-4-O-硫酸酯(3,4'-O-Dimethylellagic acid-4-O-sulfate) C16H10O11S 408.987 1 408.985 8 -3.1 329.027 6,314.004 3,
    298.980 0
    411.001 7 411.001 3 -1.0 331.044 7,
    316.020 3,
    300.999 9
    C34 15.98 槲皮素*(Quercetin) C15H10O7 301.035 4 301.034 5 -3.0 301.030 9,273.037 7,
    178.996
    5,151.002 1,
    121.029 2
    303.049 9 303.049 7 -0.8
    C35 16.47 香叶醇-1-O-呋喃阿拉伯糖基-(1→6)-β-D-吡喃葡萄糖苷(Geranyl-1-O-furanyl-arabinose-(1→6)-β-D-glucopyranoside) C21H36O10 447.223 6 447.222 1 -3.3 447.216 9,315.178 0,
    251.075
    3,221.061 3,
    191.055 2,179.053
    5
    449.238 1 449.237 4 -1.6
    C36 16.48 3, 3', 4'-O-三甲基鞣花酸-4-O-D-木糖苷(3,3',4'-O-Trimethylellagic acid-4-O-D-xyloside) C22H20O12 475.088 2 475.086 8 -2.9 343.053 9,328.026 7,
    313.001 4
    477.102 8 477.102 5 -0.6
    C37 16.83 3, 3', 4'-O-三甲基鞣花酸-4-O-硫酸酯(3,3',4'-O-Trimethylellagic acid-4-O-sulfate) C17H12O11S 423.002 8 423.001 5 -3.0 343.042 8,328.019 5,
    312.996 3
    425.017 3 425.016 9 -1.0
    C38 18.1 山柰酚*(Kaempferol) C15H10O6 285.040 5 285.039 7 -2.7 285.038 5,239.037 0,
    185.061 7,93.035
    4
    287.055 0 287.054 6 -1.4
    C39 19.11 地榆皂苷Ⅰ*
    (ZiyuglycosideⅠ)
    C41H66O13 811.447 5 811.449 9 3.0 765.444 5,603.389 0,
    585.380 2
    C40 19.14 3-氧代-12-烯-28-乌苏酸(3-Oxo-12-ene-28-ursic acid) C30H46O3 453.337 4 453.335 3 -4.6 455.352 0 455.350 9 -2.5 437.340 8,
    409.345 2,
    391.335 5
    C41 19.96 3, 3', 4'-O-三甲基鞣花酸(3,3',4'-O-Trimethylellagic acid) C17H12O8 343.045 9 343.045 2 -2.2 328.020 2,312.996 6 345.060 5 345.059 8 -1.9
    C42 22.22 坡模醇酸(Pomolic acid) C30H48O4 471.348 0 471.345 7 -4.8 473.362 5 473.360 9 -3.4 455.350 1,
    437.338 8
    C43 22.23 地榆皂苷Ⅲ
    (Ziyuglycoside Ⅲ)
    C36H58O9 679.405 2 679.404 6 -1.3 633.399 2, 471.355 1,
    453.335 0
    C44 23.11 地榆皂苷Ⅱ*
    (Ziyuglycoside Ⅱ)
    C35H56O8 603.389 5 603.390 8 2.2 585.379 8 605.404 8 605.403 0 -3.0
    C45 23.72 3, 11-二酮-19α-羟基-乌苏-12-烯-28-酸(3,11-Dioxo-19α-hydroxy-urs-12-en-28-oic acid) C30H44O5 483.311 6 483.310 3 -2.7 421.310 7 485.326 2 485.324 5 -3.5 439.318 4
    注: *表示化合物与对照品确认。
    下载: 导出CSV

    表  2  血浆、尿液和粪便中原型成分和代谢产物的鉴定

    峰号 tR/min 鉴定结果 离子模式 分子式 理论值 实测值 δ 碎片离子 来源
    C2 1.84 没食子酸, 原型(Gallic acid,parent) [M-H]- C7H6O5 169.014 3 169.015 0 4.5 169.012 6,125.025 1 粪便
    C2-1 9.48 1,3-二甲氧基没食子酸(1,3-Dimethoxygallic acid) [M-H]- C9H10O5 197.045 6 197.046 3 3.6 123.008 3 粪便
    C2-2 7.88 3-甲氧基没食子酸(3-Methoxygallic acid) [M-H]- C8H8O5 183.029 9 183.030 2 1.5 123.077 7 粪便
    C2-3 1.84 焦没食子酸(Pyrogallic acid) [M-H]- C6H6O3 125.024 4 125.025 4 8.1 081.035 8 粪便
    C2-4 7.87 C2失去2个氧原子(Two oxygen atoms loss of C2) [M-H]- C7H6O3 137.024 4 137.025 3 6.8 93.034 5,65.006 0 粪便
    C2-5 9.67 C2甲基化和葡萄糖醛酸化(Methylation and glucuronidation of C2) [M-H]- C15H18O11 373.077 6 373.077 4 -0.7 197.044 9 粪便,
    血浆
    C2-6 10.21 C2甲基化和硫酸化(Methylation and sulfated of C2) [M-H]- C9H10O8S 277.002 4 277.002 5 0.6 166.997 7 粪便,
    血浆
    C2-7 15.15 C2结合甘氨酸(Glycine conjugated of C2) [M-H]- C9H9NO6 226.035 7 226.028 0 -34 182.043 6 粪便,
    血浆
    C3 13.33 儿茶素, 原型(Gallocatechin,parent) [M-H]- C15H14O7 305.066 7 305.063 8 -9.4 305.065 3,125.036 5 粪便
    C3-1 14.86 C3甲基化(Methylation of C3) [M-H]- C16H16O7 319.089 8 319.082 5 0.6 213.068 9,187.055 5 粪便,
    尿液
    C3-2 7.01 C3氧化(Oxidation of C3) [M-H]- C15H14O8 321.067 1 321.058 6 -9.5 215.071 3,191.070 9,
    147.081 5
    粪便
    C4-1 12.31 C4甲基化(Methylation of C4) [M-H]- C16H16O7 319.089 8 319.082 5 0.6 191.070 9,131.049 5 粪便,
    尿液
    C4-2 6.03 C4氧化(Oxidation of C4) [M-H]- C15H14O8 321.067 1 321.059 8 -5.6 303.149 6,197.047 0,
    119.052 0
    粪便
    C7 14.73 Sanguiin H4, 原型(Sanguiin H4,parent) [M-H]- C27H22O18 633.073 3 633.067 3 -9.6 465.068 2 粪便
    C8 7.37 原花青素B3, 原型(Procyanidin B3,parent) [M-H]- C30H26O12 577.135 2 577.134 5 -1.2 577.135 7,451.100 4,
    425.088
    8,407.076 4,
    289.071 7,245.082
    3
    粪便
    C8-1 11.71 C8甲基化(Methylation of C8) [M-H]- C31H28O12 591.158 9 591.151 6 1.4 381.061 5,230.020 4 粪便
    C8-2 6.99 C8氧化(Oxidation of C8) [M-H]- C30H26O13 593.136 6 593.129 3 -1.3 454.135 6,397.094 0,
    137.022 1
    粪便
    C11 7.64 原花青素C2, 原型(Procyanidin C2,parent) [M-H]- C45H38O18 865.198 5 865.198 2 -0.3 695.095 0,577.132 3,
    451.097 4,407.081
    4
    粪便
    C11-1 3.67 C11氧化(Oxidation of C11) [M-H]- C45H38O19 881.201 9 881.194 6 1.3 881.188 9 粪便
    C12 8.78 儿茶素, 原型(Catechin,parent) [M-H]- C15H14O6 289.071 8 289.072 0 0.9 289.181 2,137.024 0 粪便
    C12-1 11.64 C12甲基化(Methylation of C12) [M-H]- C16H16O6 303.094 5 303.087 7 1 191.069 8,153.019 5 粪便
    C12-2 11.01 C12氧化(Oxidation of C12) [M-H]- C15H14O7 305.074 6 305.066 1 -8.5 223.098 8,165.065 2,
    125.019 7
    粪便
    C13 8.76 表儿茶素, 原型(Epicatechin,parent) [M-H]- C15H14O6 289.071 8 289.072 0 0.9 289.072 5,245.046 7,
    203.069 7
    粪便
    C13-1 16.54 C13甲基化(Methylation of C13) [M-H]- C16H16O6 303.094 5 303.087 3 -0.5 285.077 3,191.069 8,
    153.019 5,69.001
    0
    粪便
    C13-2 3.75 C13氧化(Oxidation of C13) [M-H]- C15H14O7 305.074 6 305.067 4 2.2 167.038 6,139.037 8 粪便
    C15 8.37 短叶叶酸, 原型(Brevifolincarboxylic acid,parent) [M-H]- C13H8O8 291.014 6 291.014 8 0.5 247.023 5,219.028 0,
    191.033 4
    粪便
    C17 10.73 2,6-乙酰氧基-5,7-二羟基-8-甲氧基色酮, 原型(2,6-Acetoxy-5,7-dihydroxy-8-methoxychromone,parent) [M-H]- C14H12O9 323.040 9 323.040 7 -0.4 232.040 9,219.028 4 粪便
    C20 10.21 甲氧基没食子酸甲酯-5-O-硫酸盐, 原型(Methyl methoxygallate-5-O-sulfate,parent) [M-H]- C9H10SO8 277.002 4 277.002 5 0.6 197.045 2,182.021 9,
    166.997 7
    粪便,
    血浆
    C21 10 3-O-没食子酰原花青素B3, 原型(3-O-Galloyl-procyanidin B3,parent) [M-H]- C37H30O16 729.146 1 729.146 2 0.1 729.150 3,577.137 8,
    559.120
    7,425.089 0,
    407.077
    7,289.071 6,
    269.045 1
    粪便
    C22 10.48 非瑟酮醇-(4β-8)-儿茶素,原型(Fisetinol-(4β-8)-catechin,parent) [M-H]- C30H26O11 561.140 2 561.139 7 -0.9 561.139 8,289.071 4 粪便
    C25-1 15.17 尿石素A(Urolithin A) [M-H]- C13H8O4 227.035 0 227.035 5 2.5 227.032 2,198.030 5 粪便
    C25-2 12.31 C25-1甲基化和硫酸化(Methylation and sulfated of C25-1) [M-H]- C13H8O7S 306.991 8 306.991 7 -0.3 227.034 5,198.032 2,
    183.045 2
    粪便,
    血浆,
    尿液
    C25-3 20.31 C25-1甲基化(Methylation of C25-1) [M-H]- C14H10O4 241.050 6 241.052 0 5.5 198.027 0, 154.042 9 血浆
    C25-4 13.12 C25-1葡萄糖醛酸化(Glucuronidation of C25-1) [M-H]- C19H16O10 403.067 1 403.067 0 -0.3 227.119 5 粪便,
    血浆,
    尿液
    C25-5 12.76 尿石素C(Urolithin C) [M-H]- C13H8O5 243.029 9 243.030 4 2.2 215.033 7 粪便
    C25-6 13.15 C25-5氧化(Oxidation of C25-5) [M-H]- C13H6O5 241.014 3 241.014 6 1.5 213.019 2,198.033 2,
    185.024
    5,169.027 9,
    157.028 9,129.034
    5
    粪便
    C25-7 12.09 尿石素D(Urolithin D) [M-H]- C13H8O6 259.024 8 259.025 6 3.2 241.013 5, 213.018 4 粪便,
    尿液
    C25-8 10.25 C25-7还原(Reduction of C25-7) [M-H]- C13H10O6 261.040 5 261.040 7 1 246.017 2,217.013 8,
    189.019 1
    粪便,
    尿液
    C25-9 10.12 尿石素M5(Urolithin M5) [M-H]- C13H8O7 275.019 7 275.020 1 1.4 257.009 2,229.014 0,
    203.034
    1,173.024 5,
    145.029 5
    粪便,
    尿液
    C25-10 13.78 C25甲基化(Methylation of C25) [M-H]- C15H8O8 315.021 8 315.014 5 -0.3 300.994 4, 245.002 7 粪便,
    血浆
    C27 12.65 儿茶素没食子酸, 原型(Catechin gallate,parent) [M-H]- C22H18O10 441.082 7 441.082 0 -1.6 289.187 1 粪便
    C27-1 11.82 C27还原(Hydrogenation of C27) [M-H]- C22H20O10 443.104 4 443.097 1 -2.9 381.141 9,275.091 3,
    123.009 8
    粪便,
    血浆
    C27-2 9.77 C27甲基化(Methylation of C27) [M-H]- C23H20O10 455.108 2 455.101 0 5.7 373.207 5,178.027 5,
    80.996 1
    粪便,
    尿液
    C27-3 2.56 C27氧化(Oxidation of C27) [M-H]- C22H18O11 457.086 0 457.078 8 2.4 287.032 8,275.054 5,
    257.047 2
    粪便,
    血浆
    C28-1 12.17 C28甲基化(Methylation of C28) [M-H]- C22H22O12 477.111 0 477.103 7 -0.2 395.151 3,269.045 9 粪便,
    尿液
    C28-2 6.37 C28还原(Hydrogenation of C28) [M-H]- C21H22O12 465.110 3 465.103 0 -1.9 357.066 2,289.068 7,
    151.040 5
    粪便
    C31 15.54 3, 4'-O-二甲基鞣花酸-4-O-β-D木糖苷, 原型(3, 4'-O-Dimethylellagic acid-4-O-β-D-xyloside,parent) [M-H]- C21H18O12 461.072 6 461.070 6 -4.2 329.032 6 粪便,
    血浆
    C33 16.01 3, 4'-O-二甲基鞣花酸-4-O-硫酸酯, 原型(3,4'-O-Dimethylellagic acid-4-O-sulfate,parent) [M-H]- C16H10O11S 408.987 1 408.986 2 -2.2 329.032 6,314.006 7,
    298.984 7
    粪便,
    血浆
    C34-1 10.53 C34甲基化(Methylation of C34) [M-H]- C16H12O7 315.060 9 315.051 4 1.3 315.045 0,271.168 7,
    183.105 3
    粪便,
    尿液
    C34-2 16.91 C34还原(Hydrogenation of C34) [M-H]- C15H12O7 303.061 1 303.053 8 9.1 223.096 1,123.081 2 血浆
    C34-3 8.76 C34氧化(Oxidation of C34) [M-H]- C15H10O8 317.039 1 317.031 8 4.8 237.075 8,172.075 1,
    80.965 1
    血浆
    C35 16.44 Geranyl-1-O-furanyl-arabinose(1→6)-β-D-glucopyranoside, 原型 [M-H]- C21H36O10 471.219 6 471.220 1 1.1 471.217 2,335.091 3 血浆
    C37 17.03 3, 3', 4'-O-三甲基鞣花酸-4-O-硫酸酯, 原型(3,3',4'-O-Trimethylellagic acid-4-O-sulfate,parent) [M-H]- C17H12O11S 423.002 8 423.001 4 -3.2 343.044 7,328.021 5,
    312.997 9
    粪便,
    血浆
    C38-1 21.75 C38甲基化(Methylation of C38) [M-H]- C16H12O6 299.063 3 299.056 0 -0.5 256.035 6,183.044 1,
    159.043 6
    粪便
    C38-2 13.95 C38还原(Hydrogenation of C38) [M-H]- C15H12O6 287.065 8 287.058 5 8.3 207.101 6,149.058 1,
    80.966 3
    血浆
    C38-3 9.33 C38氧化(Oxidation of C38) [M-H]- C15H10O7 301.045 4 301.038 2 9.3 177.091 5,123.007 9,
    79.958 8
    血浆
    C39 19.14 地榆皂苷Ⅰ, 原型(ZiyuglycosideⅠ, parent) [M-H]- C41H66O13 765.442 3 765.444 2 2.4 603.389 2 粪便,
    血浆
    C39-1 23.13 C39-Glu [M-H]- C35H56O8 603.390 2 603.388 2 -3.4 585.380 7 粪便
    C39-2 24.46 C39-Glu-Ara [M-H]- C30H48O4 471.348 0 471.346 3 -3.6 453.335 6 粪便
    C39-3 22.25 C39-Ara [M+Cl]- C36H58O9 669.376 4 669.375 8 -0.8 471.347 7,453.339 1 粪便
    C39-4 24.88 C39-Glu-Ara-2H [M-H]- C30H46O4 469.332 3 469.330 2 -4.6 451.320 8,407.330 7 粪便
    C39-5 22.4 C39-Glu-Ara-O [M-H]- C30H48O3 455.353 1 455.348 9 -9.1 437.336 0 尿液
    C40 24.44 3-氧代-12-烯-28-乌苏酸, 原型(3-oxo-12-ene-28-ursic acid,parent) [M+H]+ C30H46O3 455.352 0 455.350 2 -3.8 437.348 9,409.329 3,
    391.286 4
    粪便,
    血浆
    C41 19.99 3, 3', 4'-O-三甲基鞣花酸, 原型(3,3',4'-O-Trimethylellagic acid, parent) [M-H]- C17H12O8 343.045 9 343.045 5 -1.3 328.020 7,312.997 0 粪便,
    血浆
    C42 24.45 坡模醇酸, 原型(Pomolic acid,parent) [M+H]+ C30H48O4 473.362 5 473.360 6 -4 455.351 8,437.347 1 粪便,
    血浆
    C42-1 21.94 C42氧化(Oxidation of C42) [M+H]+ C30H48O5 489.348 1 489.355 4 -4.2 453.333 6,281.171 0,
    191.177 6,159.116
    5
    粪便
    C43 22.25 地榆皂苷Ⅲ, 原型(Ziyuglycoside Ⅲ,parent) [M-H]- C36H58O9 633.400 1 633.402 7 4.1 471.346 4 粪便
    C44 23.13 地榆皂苷Ⅱ, 原型(Ziyuglycoside Ⅱ,parent) [M-H]- C35H56O8 603.389 5 603.391 5 -3.3 585.380 3 粪便,
    尿液
    C45 21.76 3, 11-二酮-19α-羟基-乌苏-12-烯-28-酸, 原型(3,11-Dioxo-19α-hydroxy-urs-12-en-28-oic acid, parent) [M+H]+ C30H44O5 485.326 2 485.325 3 -1.8 439.321 5 粪便
    下载: 导出CSV
  • [1] 国家药典委员会. 中华人民共和国药典: 一部[M]. 北京: 中国医药科技出版社, 2020: 130-131.
    [2] SU XD, GUO RH, YANG SY, et al. Anti-bacterial effects of components from Sanguisorba officinalis L. on vibrio vulnificus and their soluble epoxide hydrolase inhibitory activity[J]. Nat Prod Res, 2019, 33(23): 3445-3449. doi: 10.1080/14786419.2018.1478825
    [3] WU CC, YAO MC, LI W, et al. Simultaneous determination and pharmacokinetics study of six triterpenes in rat plasma by UHPLC-MS/MS after oral administration of Sanguisorba officinalis L. extract[J]. Molecules, 2018, 23(11): 2980. doi: 10.3390/molecules23112980
    [4] SU XD, GUO RH, LI HX, et al. Anti-allergic inflammatory components from Sanguisorba officinalis L[J]. Bioorg Med Chem Lett, 2018, 28(12): 2210-2216. doi: 10.1016/j.bmcl.2018.04.033
    [5] 许维桐, 霍志鹏, 雷磊, 等. HPLC-IT-TOF/MS分析地榆水煎液的化学成分群[J]. 中草药, 2018, 49(6): 1277-1288. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYO201806008.htm
    [6] LACHOWICZ S, OSZMIA AN' SKI J, RAPAK A, et al. Profile and content of phenolic compounds in leaves, flowers, roots, and stalks of Sanguisorba officinalis L. determined with the LC-DAD-ESI-QTOF-MS/MS analysis and their in vitro antioxidant, antidiabetic, antiproliferative potency[J]. Pharmaceuticals, 2020, 13(8): 191. doi: 10.3390/ph13080191
    [7] 王森业, 殷博迪, 王玉宁, 等. 不同方法提取地榆总三萜含量的比较及其抗氧化活性研究[J]. 食品研究与开发, 2019, 40(6): 111-115. doi: 10.3969/j.issn.1005-6521.2019.06.020
    [8] ZHU HL, CHEN G, CHEN SN, et al. Characterization of polyphenolic constituents from Sanguisorba officinalis L. and its antibacterial activity[J]. Eur Food Res Technol, 2019, 245(7): 1487-1498. doi: 10.1007/s00217-019-03276-2
    [9] 黄楷迪, 朱西杰, 牛阳, 等. 复方蜥蜴散大鼠血浆、尿液、胆汁、粪便中代谢产物的鉴定[J/OL]. 中草药, 1-10. https://kns.cnki.net/kcms/detail/12.1108.R.20210527.0856.004.html.
    [10] ZHU C, CAI T, JIN Y, et al. Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes[J]. Pharmacol Res, 2020, 159: 104935. doi: 10.1016/j.phrs.2020.104935
    [11] 康立欣, 许振鹏, 刘艳, 等. 关黄柏水提物在大鼠血清、尿液和粪便中原型成分及其代谢产物的UPLC-Orbitrap Fusion Lumos Tribrid-MS鉴定[J]. 中国实验方剂学杂志, 2021, 27(11): 139-146. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202111021.htm
    [12] 吕苗凯, 霍志鹏, 刘元雪, 等. 地榆成分在D101型大孔树脂和聚酰胺树脂上保留行为的LCMS-IT-TOF分析[J]. 中国实验方剂学杂志, 2020, 26(14): 152-163. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSFX202014023.htm
    [13] WANG GJ, FU HX, YE W, et al. Comprehensive characterization of the in vitro and in vivo metabolites of ziyuglycoside Ⅰ in rat microsome, intestinal flora, excretion specimen and fresh tissues based on LC-Q-TOF/MS[J]. J Pharm Biomed Anal, 2016, 128: 191-200. doi: 10.1016/j.jpba.2016.05.032
    [14] 周本宏, 汪静, 吴玥, 等. 地榆鞣质在大鼠尿液中代谢产物分析[J]. 中国现代中药, 2017, 19(6): 784-793. https://www.cnki.com.cn/Article/CJFDTOTAL-YJXX201706012.htm
    [15] 罗艳, 王寒, 原忠. 地榆中三萜皂苷类成分及其抗炎活性研究[J]. 中国药物化学杂志, 2008, 18(2): 138-141. doi: 10.3969/j.issn.1005-0108.2008.02.015
    [16] WANG L, LI S, LI J, et al. Comprehensive metabolic profiling of Alismatis rhizoma triterpenes in rats based on characteristic ions and a triterpene database[J]. J Pharm Anal, 2021, 11(1): 96-107. doi: 10.1016/j.jpha.2020.03.010
    [17] 肖玉欣, 王楠, 王婧, 等. 鞣花酸和尿石素类代谢产物的生物活性及其对肠道健康的积极作用[J/OL]. 食品科学, 1-14. https://kns.cnki.net/kcms/detail/11.2206.TS.20210602.1339.002.html.
    [18] 尹培培, 闫林林, 曹若愚, 等. 鞣花酸代谢产物: 尿石素的研究进展[J]. 食品科学, 2015, 36(7): 256-260. https://www.cnki.com.cn/Article/CJFDTOTAL-SPKX201507047.htm
  • 加载中
图(4) / 表(2)
计量
  • 文章访问数:  226
  • HTML全文浏览量:  26
  • PDF下载量:  104
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-07-30
  • 网络出版日期:  2021-12-21
  • 刊出日期:  2021-11-10
  • 发布日期:  2021-11-15

目录

    /

    返回文章
    返回